Adiponectin has aroused increasing interest because of its insulin-sensitising [4], [5], anti-atherosclerotic [6] and anti-inflammatory properties [7] and its levels have been shown to be inversely correlated with obesity [8] and type 2 diabetes mellitus [9], [10]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.